UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1651
Astec Industries
ASTE
$880M
| $2.55M | ﹤0.01% |
52,954
-40,530
| -43% | -$1.77M |
2023 Q1
10 quarters
|
|
1652
Calumet Specialty Products
CLMT
$5.08B
| $2.55M | ﹤0.01% |
139,640
-142,726
| -51% | -$2.35M |
2024 Q4
3 quarters
|
|
1653
Sylvamo
SLVM
$1.3B
| $2.54M | ﹤0.01% |
57,549
-45,639
| -44% | -$2.11M |
2021 Q4
15 quarters
|
|
1654
Kaiser Aluminum
KALU
$2.41B
| $2.54M | ﹤0.01% |
32,922
-24,124
| -42% | -$1.92M |
2023 Q1
10 quarters
|
|
1655
Alpha Metallurgical Resources
AMR
$2.11B
| $2.54M | ﹤0.01% |
15,460
-16,316
| -51% | -$2.26M |
2023 Q1
10 quarters
|
|
1656
Ivanhoe Electric
IE
$1.38B
| $2.53M | ﹤0.01% |
201,908
-111,469
| -36% | -$1.1M |
2023 Q1
10 quarters
|
|
1657
Novavax
NVAX
$1.86B
| $2.51M | ﹤0.01% |
289,674
-155,913
| -35% | -$1.21M |
2020 Q2
21 quarters
|
|
1658
DELISTED
Avanos Medical
AVNS
| $2.49M | ﹤0.01% |
215,344
-63,122
| -23% | -$739K |
2014 Q4
43 quarters
|
|
1659
Middlesex Water
MSEX
$1.03B
| $2.49M | ﹤0.01% |
45,996
-28,783
| -38% | -$1.54M |
2014 Q1
46 quarters
|
|
1660
Rush Street Interactive
RSI
$2.14B
| $2.48M | ﹤0.01% |
121,075
-86,208
| -42% | -$1.63M |
2024 Q3
4 quarters
|
|
1661
A10 Networks
ATEN
$1.78B
| $2.47M | ﹤0.01% |
136,287
-163,192
| -54% | -$2.95M |
2023 Q1
10 quarters
|
|
1662
Ouster
OUST
$2.05B
| $2.46M | ﹤0.01% |
+91,110
| New | +$2.54M |
2025 Q3
0 quarters
|
|
1663
Blue Bird Corp
BLBD
$1.95B
| $2.44M | ﹤0.01% |
42,392
-27,598
| -39% | -$1.44M |
2023 Q1
10 quarters
|
|
1664
TIC Solutions Inc
TIC
$1.89B
| $2.43M | ﹤0.01% |
182,258
+71,435
| +64% | +$815K |
2025 Q2
1 quarter
|
|
1665
Janus International
JBI
$570M
| $2.43M | ﹤0.01% |
245,761
-166,385
| -40% | -$1.6M |
2021 Q4
15 quarters
|
|
1666
Astrana Health
ASTH
$1.83B
| $2.42M | ﹤0.01% |
85,462
-72,977
| -46% | -$1.98M |
2019 Q4
23 quarters
|
|
1667
KE Holdings
BEKE
$19.8B
| $2.42M | ﹤0.01% |
127,427
-230,114
| -64% | -$4.31M |
2020 Q3
20 quarters
|
|
1668
Sezzle
SEZL
$4.31B
| $2.42M | ﹤0.01% |
30,415
-19,146
| -39% | -$2.2M |
2024 Q4
3 quarters
|
|
1669
Dave Inc
DAVE
$4.69B
| $2.42M | ﹤0.01% |
12,119
-12,877
| -52% | -$2.78M |
2025 Q1
2 quarters
|
|
1670
Aurinia Pharmaceuticals
AUPH
$2.2B
| $2.41M | ﹤0.01% |
218,538
-225,040
| -51% | -$2.46M |
2019 Q2
25 quarters
|
|
1671
Origin Bancorp
OBK
$1.59B
| $2.41M | ﹤0.01% |
69,836
-62,941
| -47% | -$2.33M |
2020 Q4
19 quarters
|
|
1672
German American Bancorp
GABC
$1.88B
| $2.41M | ﹤0.01% |
61,331
-44,172
| -42% | -$1.78M |
2019 Q3
24 quarters
|
|
1673
V2X
VVX
$2.2B
| $2.4M | ﹤0.01% |
41,399
-28,810
| -41% | -$1.54M |
2019 Q4
23 quarters
|
|
1674
Alight
ALIT
$237M
| $2.4M | ﹤0.01% |
36,819
-32,917
| -47% | -$2.91M |
2022 Q2
13 quarters
|
|
1675
Stepan Co
SCL
$1.41B
| $2.4M | ﹤0.01% |
50,306
-35,880
| -42% | -$1.86M |
2013 Q2
49 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.